Clinical Trials
18 trialsNCT06955910 2026-05-12
Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies.
Istituto Oncologico Veneto IRCCS
Active not recruiting
NCT06461780 2026-04-30
Exploring Physical and Psychological Needs and Quality of Life in Patients With Advanced Cancer Receiving Immunotherapy
Taipei Veterans General Hospital, Taiwan
Recruiting
NCT07215611 2026-04-30
Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas
M.D. Anderson Cancer Center
Recruiting
NCT07083271 2026-02-20
FIN-CARE
Ankara Etlik City Hospital
Completed
NCT07354165 2026-01-21
VOICE - GIM36
National Cancer Institute, Naples
Recruiting
NCT07175350 2025-09-16
FIT-RT
University of Campania Luigi Vanvitelli
Recruiting
NCT05104632 2025-06-15
Financial Toxicity in Breast Cancer Surgery
McMaster University
Active not recruiting
NCT04032483 2024-03-13
A Survey of Financial Toxicity in Rural Cancer Patients
Dartmouth-Hitchcock Medical Center
Completed
NCT05334290 2024-03-12
FiReNEN
IRCCS San Raffaele
Unknown
NCT05319925 2023-12-15
FIAT
University Hospital Heidelberg
Completed
NCT06032975 2023-11-13
MITO45-ProFFiT
National Cancer Institute, Naples
Recruiting
NCT05964816 2023-08-01
A Longitudinal Study of the Trajectory of Financial Toxicity and Its Relationship With Symptom Burden in Breast Cancer Patients
Fudan University
Unknown
NCT05917444 2023-06-23
Managing Breast Cancer Treatment: Dyad's Perspectives on Treatment Decision, Financial and Family Burden.
National Taiwan University Hospital
Unknown
NCT03473379 2023-03-24
PROFTC-I
National Cancer Institute, Naples
Unknown
NCT03257917 2019-08-26
Understanding Value in Metastatic Breast Cancer
University of Alabama at Birmingham
Completed
NCT01520194 2016-05-10
GWburden
BEMFAM-Bem Estar Familiar
Completed
NCT01381601 2013-05-13
Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (Pharmetrics)
GlaxoSmithKline
Completed
NCT01381614 2013-05-13
Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (IHCIS)
GlaxoSmithKline
Completed